These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 196497)

  • 21. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
    Fuller RW; Clemens JA; Hynes MD
    J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
    Vigouret JM; Bürki HR; Jaton AL; Züger PE; Loew DM
    Pharmacology; 1978; 16 Suppl 1():156-73. PubMed ID: 565520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
    Ziegler MG; Kennedy B; Holland OB; Murphy D; Lake CR
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):175-9. PubMed ID: 3158615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of schizophrenia and the striatum.
    Klawans HL; Goetz C; Westheimer R
    Dis Nerv Syst; 1972 Nov; 33(11):711-9. PubMed ID: 4266033
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of basal ganglia in rhythmic movement.
    Freund HJ; Hefter H
    Adv Neurol; 1993; 60():88-92. PubMed ID: 8420222
    [No Abstract]   [Full Text] [Related]  

  • 28. Central monoamine synapses as sites of action for ergot drugs.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B
    Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Hruska RE; Silbergeld EK
    J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover.
    Snider SR; Hutt C; Stein B; Prasad AL; Fahn S
    J Pharm Pharmacol; 1976 Jul; 28(7):563-6. PubMed ID: 8610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychopharmacology of phencyclidine.
    Marwah J; Pitts DK
    NIDA Res Monogr; 1986; 64():127-33. PubMed ID: 3012344
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Renal interactions of prolactin and bromocriptine.
    Mahajan KK; Manku MS; Davidson H; James MF; Robinson CJ; Horrobin DF
    J Endocrinol; 1976 Mar; 68(3):14P. PubMed ID: 1255072
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
    Serby M; Angrist B; Lieberman A
    Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug effects on pre- and postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism.
    McLellan DL
    Br Med J; 1976 Jul; 2(6029):235-6. PubMed ID: 989742
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Platelet and coagulation studies in patients treated with bromocriptine.
    Conard J; Samama M; Bousser MG; Bories F
    Br Med J; 1976 Aug; 2(6034):529-30. PubMed ID: 953674
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of pergolide and bromocriptine on male rat sexual behavior.
    Ahlenius S; Engel J; Larsson K; Svensson L
    J Neural Transm; 1982; 54(3-4):165-70. PubMed ID: 7130971
    [No Abstract]   [Full Text] [Related]  

  • 39. The dynamics of neurological disease: integrating computational, experimental and clinical neuroscience.
    Coombes S; Terry JR
    Eur J Neurosci; 2012 Jul; 36(2):2118-20. PubMed ID: 22805057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurology in 1977].
    Rosa A
    Rev Prat; 1977 Jun; 27(35):2215-20. PubMed ID: 143056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.